RULEMAKING: Public Health - Oversight Reports

February 08, 2022
Second Oversight Report for the proposed additions to the Newborn Screening Panel
January 21, 2022
Second oversight report for the proposed Consumable Hemp Products rule to be published in February 2022.
December 10, 2021
First oversight for proposed rule to include Spinal Muscular Atrophy (SMA), Mucopolysaccharidosis (MPS I), and Glycogen Storage Diseases Type II (Pompe Disease) to the Louisiana Newborn Screening Panel.
November 10, 2021
In accordance with R.S. 49:968, the 2nd Legislative Oversight Committee Report for the proposed Immunization Schedule rule has been submitted to the applicable oversight committees.
September 10, 2021
In accordance with R.S. 49:968, the 1st Legislative Oversight Committee Report for the proposed Immunization Schedule rule has been submitted to the applicable oversight committees.
March 10, 2021
Under the authority of R.S. 36:254(B)(7) and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, notice is hereby given that the Louisiana Department of Health, Office of Public Health (LDH-OPH) intends to amend Chapter 61 (Automated External Defibrillators) of Subpart 3 (Licensing and Certification) of Part I (General Administration) of Title 48 (Public Health—General) of the Louisiana Administrative Code (LAC). The proposed amendments are necessary to update the LAC to match the amended R.S. 40:1137.3.
March 10, 2021
This proposed rule eliminates the current requirement for annual TB testing for most employees, students or volunteers at any medical or 24-hour residential facility requiring licensing by the Louisiana Department of Health (LDH), or at any LDH-OPH parish health unit or an LDH-OPH out-patient health care facility.
March 10, 2021
In accordance with R.S. 49:968, the 2nd Legislative Oversight Committee Report for the Industrial Hemp-Derived Cannabidiol Products Registration rule has been submitted to the applicable oversight committees.
Accessibility